Junqi Liu

6 Shuangyong Road
Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Integrating single cell- and spatial- resolved transcriptomics unravels the inter-tumor heterogeneity and immunosuppressive landscape in HBV- and Clonorchis sinensis-associated hepatocellular carcinoma.

Integrating single cell- and spatial- resolved transcriptomics unravels the inter-tumor heterogeneity and immunosuppressive landscape in HBV- and Clonorchis sinensis-associated hepatocellular carcinoma.

Journal: Molecular cancer

Published: March 12, 2025

Risk assessment and exposure patterns of hydroxypolycyclic aromatic hydrocarbons in elderly population: Insights from urinary metabolite levels and dietary habits.

Risk assessment and exposure patterns of hydroxypolycyclic aromatic hydrocarbons in elderly population: Insights from urinary metabolite levels and dietary habits.

Journal: Journal of environmental sciences (China)

Published: February 11, 2025

Pan-cancer analysis identifies DBF4B as an immunologic and prognostic biomarker.

Pan-cancer analysis identifies DBF4B as an immunologic and prognostic biomarker.

Journal: Journal of Cancer

Published: December 20, 2024

Safety of immune checkpoint inhibitors in cancer patients with COVID-19: A review.

Safety of immune checkpoint inhibitors in cancer patients with COVID-19: A review.

Journal: Medicine

Published: November 21, 2024

DPF2 overexpression correlates with immune infiltration and dismal prognosis in hepatocellular carcinoma.

DPF2 overexpression correlates with immune infiltration and dismal prognosis in hepatocellular carcinoma.

Journal: Journal of Cancer

Published: April 17, 2024

Sarcosine dehydrogenase as an immune infiltration-associated biomarker for the prognosis of hepatocellular carcinoma.

Sarcosine dehydrogenase as an immune infiltration-associated biomarker for the prognosis of hepatocellular carcinoma.

Journal: Journal of Cancer

Published: August 28, 2023

Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma.

Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma.

Journal: Medicine

Published: August 21, 2023

SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma.

SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma.

Journal: Aging

Published: May 08, 2023

Outer dynein arm docking complex subunit 2 polymorphism rs7893462 modulates hepatocellular carcinoma susceptibility and can serve as an overall survival biomarker for hepatitis B virus-related hepatocellular carcinoma after hepatectomy: a cohort study with a long-term follow-up.

Outer dynein arm docking complex subunit 2 polymorphism rs7893462 modulates hepatocellular carcinoma susceptibility and can serve as an overall survival biomarker for hepatitis B virus-related hepatocellular carcinoma after hepatectomy: a cohort study with a long-term follow-up.

Journal: World journal of surgical oncology

Published: April 28, 2023

MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling.

MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling.

Journal: Cell death discovery

Published: May 17, 2022

Prognostic value of Kinesin-4 family genes mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy.

Prognostic value of Kinesin-4 family genes mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy.

Journal: Cancer medicine

Published: June 20, 2019

Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.

Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.

Journal: Oncology reports

Published: April 25, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026